What is Innovex International Inc's earnings per share (EPS)?

Innovex International Inc (INVX) reported diluted earnings per share of $1.20 for fiscal year 2025. This represents a -56.7% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Innovex International Inc Financials

INVX

Trailing 12 months to June 30, 2026

Revenue $997.5M +11.5% YoY

Net Income $61.6M -57.4% YoY

EPS (Diluted) $0.89 -57.8% YoY

Free Cash Flow Not reported for the trailing 12 months

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 4, 2026 Currency USD FYE December

Innovex International Inc (INVX) reported $997.5M in revenue over the twelve months to Jun 30, 2026, up 11.5% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI INVX FY2025 2026-08-15

Cash conversion is strengthening as growth accelerates, while gross-margin pressure shifts the operating challenge below production costs.

In FY2025, operating cash flow of $190.9M exceeded net income of $83.3M, showing that accounting earnings understated the cash produced during the year. Cash then rose from $73.3M in FY2024 to $203.4M in FY2025, indicating that liquidity was supported by operations rather than depending primarily on new borrowing.

Revenue expanded from $660.8M in FY2024 to $978.3M in FY2025, but the business did not preserve its gross economics. Gross margin fell to 31.0%, yet operating margin recovered to 13.6%, pointing to improved cost absorption below gross profit rather than broad-based margin expansion.

Debt-to-equity moved from 0.1x in FY2023 to 0.0x in FY2025, so expansion was financed with little balance-sheet leverage. Inventory and receivables together reached $486.2M in FY2025, more than twice cash of $203.4M, making working-capital execution a more prominent operating feature than debt service.

Financial Health Signals

Financial Health Score 73/100

Scored as: Energy peer group

Scored against energy companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Innovex International Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Growth

Leverage

Liquidity

Cash Flow

Returns

Altman Z-Score Safe

7.98

Innovex International Inc scores 7.98, well above the 2.99 safe threshold. The score is driven primarily by a large market capitalization ($2.1B) relative to total liabilities ($210.6M). This indicates low bankruptcy risk based on profitability, leverage, and asset efficiency.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Strong

7/9

Innovex International Inc passes 7 of 9 financial strength tests. 3 of 4 profitability signals pass, all 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed

2.29x

For every $1 of reported earnings, Innovex International Inc generates $2.29 in operating cash flow ($190.9M OCF vs $83.3M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Interest Coverage Safe

51.37x

Innovex International Inc earns $51.37 in operating income for every $1 of interest expense ($132.6M vs $2.6M). This wide margin provides strong safety for debt servicing, even if earnings decline temporarily.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$978.3M

YoY+48.0%

5Y CAGR+21.8%

10Y CAGR+1.5%

Innovex International Inc generated $978.3M in revenue in fiscal year 2025. This represents an increase of 48.0% from the prior year.

EBITDA

$193.4M

YoY+140.9%

10Y CAGR-3.6%

Innovex International Inc's EBITDA was $193.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 140.9% from the prior year.

Net Income

$83.3M

YoY-40.6%

10Y CAGR-8.0%

Innovex International Inc reported $83.3M in net income in fiscal year 2025. This represents a decrease of 40.6% from the prior year.

EPS (Diluted)

$1.20

YoY-56.7%

Innovex International Inc earned $1.20 per diluted share (EPS) in fiscal year 2025. This represents a decrease of 56.7% from the prior year.

Cash & Balance Sheet

Cash & Debt

$203.4M

YoY+177.6%

5Y CAGR-10.1%

10Y CAGR-6.1%

Innovex International Inc held $203.4M in cash against $18.9M in long-term debt as of fiscal year 2025.

Shares Outstanding

69M

YoY-0.2%

Innovex International Inc had 69M shares outstanding in fiscal year 2025. This represents a decrease of 0.2% from the prior year.

Free Cash Flow

Not reported for fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Gross Margin

31.0%

YoY-4.2pp

5Y CAGR+4.9pp

10Y CAGR-14.6pp

Innovex International Inc's gross margin was 31.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs. This is down 4.2 percentage points from the prior year.

Operating Margin

13.6%

YoY+6.1pp

5Y CAGR+31.0pp

10Y CAGR-15.9pp

Innovex International Inc's operating margin was 13.6% in fiscal year 2025, reflecting core business profitability. This is up 6.1 percentage points from the prior year.

Net Margin

8.5%

YoY-12.7pp

5Y CAGR+16.9pp

10Y CAGR-14.2pp

Innovex International Inc's net profit margin was 8.5% in fiscal year 2025, showing the share of revenue converted to profit. This is down 12.7 percentage points from the prior year.

Return on Equity

7.9%

YoY-6.8pp

5Y CAGR+10.8pp

10Y CAGR-6.6pp

Innovex International Inc's ROE was 7.9% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 6.8 percentage points from the prior year.

Capital Allocation

R&D Spending

$6.7M

YoY+81.1%

Innovex International Inc invested $6.7M in research and development in fiscal year 2025. This represents an increase of 81.1% from the prior year.

Share Buybacks

$9.3M

5Y CAGR-18.0%

10Y CAGR-18.9%

Innovex International Inc spent $9.3M on share buybacks in fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Capital Expenditures

Not reported for fiscal year 2025.

INVX Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

INVX quarterly income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	$997.5M	$978.3M+48.0%	$660.8M+18.9%	$555.5M+53.5%	$361.9M+12.2%	$322.4M-11.7%	$365.0M-12.0%	$414.8M+7.8%	$384.6M-15.6%	$455.5M-15.5%	$538.7M-36.2%	$844.3M-9.3%	$931.0M+6.7%	$872.4M+19.0%	$733.0M+21.9%	$601.3M
Cost of Revenue	$674.3M	$675.0M+57.6%	$428.2M+18.9%	$360.1M+16.5%	$309.1M-0.1%	$309.3M+14.7%	$269.7M-8.6%	$295.0M+0.5%	$293.6M-11.1%	$330.2M+0.6%	$328.4M-28.5%	$459.3M-10.6%	$513.5M-0.1%	$513.9M+13.8%	$451.7M+24.8%	$361.8M
Gross Profit	$323.2M	$303.3M+30.4%	$232.6M+19.0%	$195.4M+269.8%	$52.9M+300.9%	$13.2M-86.2%	$95.3M-20.5%	$119.8M+31.6%	$91.1M-27.3%	$125.2M-40.5%	$210.3M-45.4%	$385.0M-7.8%	$417.4M+16.4%	$358.5M+27.4%	$281.4M+17.5%	$239.5M
R&D Expenses	N/A	$6.7M+81.1%	$3.7M+23.3%	$3.0M+20.0%	$2.5M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
SG&A Expenses	$148.4M	$128.8M+10.9%	$116.2M+59.6%	$72.8M+23.0%	$59.2M-48.5%	$115.0M+21.0%	$95.1M-3.4%	$98.4M-3.6%	$102.1M-10.1%	$113.6M+113.3%	$53.2M-39.5%	$88.0M-5.1%	$92.8M-2.2%	$94.8M+15.3%	$82.2M+16.6%	$70.5M
Operating Income	$100.0M	$132.6M+170.2%	$49.1M-49.6%	$97.3M+28.3%	$75.8M+160.5%	-$125.3M-97.2%	-$63.6M-2367.5%	$2.8M+102.3%	-$122.7M-77.5%	-$69.1M-161.3%	$112.9M-54.6%	$248.8M-10.7%	$278.7M+24.7%	$223.5M+38.3%	$161.7M+24.7%	$129.6M
Interest Expense	$290K	$2.6M+6.3%	$2.4M-55.9%	$5.5M+36.5%	$4.0M+412.6%	$787K+26.7%	$621K+97.8%	$314K+7.9%	$291K+304.2%	$72K+157.1%	$28K+133.3%	$12K-65.7%	$35K0.0%	$35K+9.4%	$32K-39.6%	$53K
Income Tax	$37.2M	$45.2M+1718.7%	$2.5M-87.8%	$20.4M+111.8%	$9.7M+227.6%	$2.9M+109.4%	-$31.3M-459.2%	$8.7M+145.1%	-$19.3M-155.1%	$35.0M+54.5%	$22.6M-60.8%	$57.8M-18.3%	$70.7M+30.2%	$54.3M+26.5%	$42.9M+23.5%	$34.7M
Net Income	$61.6M	$83.3M-40.6%	$140.3M+89.8%	$73.9M+16.8%	$63.3M+149.2%	-$128.5M-317.6%	-$30.8M-1888.8%	$1.7M+101.8%	-$95.7M+4.9%	-$100.6M-208.0%	$93.2M-51.4%	$192.0M-8.0%	$208.7M+22.9%	$169.8M+42.5%	$119.2M+25.1%	$95.3M
EPS (Diluted)	$0.89	$1.20-56.7%	$2.77	$2.29+13.9%	$2.01+155.4%	-$3.63-317.2%	-$0.87-1840.0%	$0.05+101.9%	-$2.58+4.1%	-$2.69-208.9%	$2.47-50.4%	$4.98-4.0%	$5.19+24.8%	$4.16+41.5%	$2.94+24.6%	$2.36

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Revenue	$244.9M+2.5%	$239.0M-12.6%	$273.6M+14.0%	$240.0M+7.0%	$224.2M-6.7%	$240.4M-13.6%	$278.3M+83.3%	$151.8M
Cost of Revenue	$161.2M+4.4%	$154.5M-20.5%	$194.5M+18.5%	$164.1M+7.6%	$152.5M-7.0%	$163.9M-1.1%	$165.8M+67.3%	$99.1M
Gross Profit	$83.6M-1.0%	$84.5M+6.8%	$79.1M+4.2%	$75.9M+5.9%	$71.7M-6.3%	$76.5M-32.0%	$112.5M+113.6%	$52.7M
SG&A Expenses	$39.1M-6.4%	$41.7M+30.3%	$32.0M-9.9%	$35.6M+23.4%	$28.8M-10.9%	$32.3M-15.5%	$38.3M+0.8%	$38.0M
Operating Income	$33.8M+254.7%	-$21.8M-184.6%	$25.8M-58.6%	$62.3M+174.4%	$22.7M+3.9%	$21.9M-18.8%	$26.9M+303.6%	-$13.2M
Interest Expense	-$653K-68.3%	-$388K-159.3%	$654K-3.4%	$677K+22.9%	$551K-21.3%	$700K+86.7%	$375K-48.6%	$729K
Income Tax	$10.4M+310.8%	-$4.9M-137.9%	$13.0M-30.6%	$18.7M+171.9%	$6.9M+4.3%	$6.6M+251.0%	-$4.4M-69.1%	-$2.6M
Net Income	$25.0M+250.1%	-$16.7M-219.4%	$14.0M-64.4%	$39.2M+155.6%	$15.3M+4.0%	$14.8M-53.6%	$31.8M-61.5%	$82.6M
EPS (Diluted)	$0.36+250.0%	-$0.24-220.0%	$0.20-64.9%	$0.57+159.1%	$0.22+4.8%	$0.21+167.7%	-$0.31-115.6%	$1.99

Not reported in any period shown, so not listed: R&D Expenses.

INVX Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

INVX quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$1.3B+5.9%	$1.2B+151.9%	$475.3M-51.0%	$970.0M-4.0%	$1.0B-12.3%	$1.2B-4.6%	$1.2B+1.2%	$1.2B-14.8%	$1.4B-4.2%	$1.5B+2.3%	$1.4B-1.4%	$1.4B+3.8%	$1.4B+11.8%	$1.2B+15.1%	$1.1B
Current Assets	$728.0M+13.5%	$641.4M+122.5%	$288.3M-61.6%	$750.0M+0.7%	$745.1M-13.7%	$863.2M-2.0%	$880.5M+3.2%	$853.0M-15.4%	$1.0B-4.6%	$1.1B-6.0%	$1.1B-0.3%	$1.1B+4.3%	$1.1B+16.9%	$924.4M+15.6%	$799.3M
Cash & Equivalents	$203.4M+177.6%	$73.3M-60.9%	$187.3M-27.8%	$259.4M-27.0%	$355.5M+2.7%	$346.0M-13.3%	$398.9M-4.6%	$418.1M-15.2%	$493.2M+16.5%	$423.5M+11.1%	$381.3M+27.7%	$298.7M-22.3%	$384.4M+49.4%	$257.2M-13.9%	$298.6M
Inventory	$248.4M-8.4%	$271.2M+92.1%	$141.2M-3.3%	$146.0M+0.2%	$145.7M-31.4%	$212.5M+3.6%	$205.1M+7.3%	$191.2M-34.3%	$291.1M-18.1%	$355.4M+3.2%	$344.5M-12.3%	$392.6M+6.6%	$368.4M+1.7%	$362.2M+30.4%	$277.8M
Accounts Receivable	$237.8M-0.7%	$239.5M+102.4%	$118.4M+30.3%	$90.9M-9.6%	$100.5M-13.5%	$116.2M+8.0%	$107.6M-9.3%	$118.7M-38.1%	$191.6M-10.2%	$213.5M-33.2%	$319.8M-14.5%	$374.0M+33.9%	$279.3M+6.1%	$263.2M+46.2%	$180.1M
Goodwill	$99.7M+65.7%	$60.2M+151.4%	$23.9M0.0%	$23.9M	N/A	N/A	$7.9M+3.0%	$7.7M-83.8%	$47.6M+38.6%	$34.4M	$0	N/A	N/A	N/A	N/A
Total Liabilities	$210.6M-12.0%	$239.3M+63.5%	$146.4M-79.6%	$718.7M-13.3%	$829.4M+656.4%	$109.6M-5.4%	$115.9M+20.3%	$96.3M-8.5%	$105.3M+0.3%	$105.0M+1.1%	$103.8M-49.1%	$204.1M+31.8%	$154.8M-6.2%	$165.0M+2.7%	$160.6M
Current Liabilities	$148.2M-8.9%	$162.7M+106.9%	$78.6M-10.2%	$87.6M-6.5%	$93.7M+9.5%	$85.5M-11.8%	$96.9M+18.9%	$81.5M-18.4%	$99.9M-1.5%	$101.5M+0.7%	$100.8M-49.2%	$198.6M+32.9%	$149.4M-3.6%	$155.1M+2.7%	$151.0M
Long-Term Debt	$18.9M-24.0%	$24.9M-38.6%	$40.6M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	$57K
Total Equity	$1.1B+10.4%	$958.2M+191.3%	$328.9M+30.9%	$251.3M+39.2%	$180.6M-82.7%	$1.0B-4.5%	$1.1B-0.5%	$1.1B-15.3%	$1.3B-4.6%	$1.4B+2.4%	$1.3B+6.4%	$1.2B+0.3%	$1.2B+16.5%	$1.1B+15.3%	$925.2M
Retained Earnings	$285.3M+35.0%	$211.3M+44.8%	$145.9M-84.6%	$950.2M-2.4%	$973.1M-13.5%	$1.1B-4.7%	$1.2B-2.1%	$1.2B-13.9%	$1.4B-6.7%	$1.5B+5.3%	$1.4B+11.5%	$1.3B+19.5%	$1.1B+18.9%	$900.0M+15.3%	$780.8M

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Total Assets	$1.3B+3.1%	$1.3B+1.5%	$1.3B+1.1%	$1.3B+2.2%	$1.2B+2.6%	$1.2B-0.1%	$1.2B+5.7%	$1.1B
Current Assets	$788.5M+4.7%	$752.9M+3.4%	$728.0M+2.5%	$710.4M+6.0%	$670.1M+5.9%	$632.6M-1.4%	$641.4M-5.3%	$677.3M
Cash & Equivalents	$222.1M+10.6%	$200.7M-1.3%	$203.4M+24.5%	$163.4M+137.5%	$68.8M+1.0%	$68.1M-7.0%	$73.3M-26.6%	$99.9M
Inventory	$264.8M+4.7%	$253.0M+1.8%	$248.4M-9.7%	$275.2M-1.2%	$278.5M+3.4%	$269.3M-0.7%	$271.2M-8.9%	$297.5M
Accounts Receivable	$240.1M-2.3%	$245.6M+3.3%	$237.8M+7.9%	$220.4M-0.3%	$221.0M-6.4%	$236.0M-1.5%	$239.5M+6.4%	$225.1M
Goodwill	$106.0M+6.3%	$99.8M0.0%	$99.7M+4.5%	$95.4M+1.3%	$94.1M+24.6%	$75.6M+25.6%	$60.2M+151.4%	$23.9M
Total Liabilities	$269.2M+4.9%	$256.8M+21.9%	$210.6M-2.0%	$215.0M-7.2%	$231.5M+6.4%	$217.6M-9.1%	$239.3M+4.8%	$228.4M
Current Liabilities	$157.5M+6.6%	$147.8M-0.3%	$148.2M-0.4%	$148.7M+2.0%	$145.7M-0.1%	$145.8M-10.4%	$162.7M-6.9%	$174.8M
Long-Term Debt	$19.0M+5.5%	$18.0M-4.7%	$18.9M-5.8%	$20.1M-42.2%	$34.8M+76.7%	$19.7M-21.0%	$24.9M+101.6%	$12.4M
Total Equity	$1.1B+2.7%	$1.0B-2.5%	$1.1B+1.8%	$1.0B+4.4%	$995.6M+1.8%	$978.4M+2.1%	$958.2M+5.9%	$904.4M
Retained Earnings	$279.5M+9.8%	$254.5M-10.8%	$285.3M+5.1%	$271.3M+16.9%	$232.1M+3.0%	$225.4M+6.7%	$211.3M+17.7%	$179.5M

INVX Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

INVX quarterly cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	$157.5M	$190.9M+104.3%	$93.4M+23.2%	$75.9M+1405.5%	-$5.8M-115.1%	$38.4M+282.2%	-$21.1M-243.7%	$14.7M-67.7%	$45.5M-57.9%	$108.0M-56.2%	$246.5M+29.6%	$190.2M+27.4%	$149.3M-8.0%	$162.2M+2088.3%	-$8.2M-108.0%	$101.9M
Capital Expenditures	N/A	N/A	N/A	$32.6M+72.9%	$18.9M+88.8%	$10.0M-16.4%	$11.9M+3.8%	$11.5M-64.1%	$32.1M+16.1%	$27.6M+7.2%	$25.8M-4.9%	$27.1M-36.4%	$42.5M-0.2%	$42.6M-16.0%	$50.8M-9.7%	$56.2M
Free Cash Flow	N/A	N/A	N/A	$43.2M+275.2%	-$24.7M-186.8%	$28.4M+186.1%	-$33.0M-1139.7%	$3.2M-76.4%	$13.4M-83.3%	$80.4M-63.6%	$220.8M+35.4%	$163.1M+52.7%	$106.8M-10.7%	$119.6M+302.9%	-$58.9M-229.1%	$45.6M
Investing Cash Flow	$48.8M	-$18.7M-123.9%	$78.4M+341.9%	-$32.4M+13.6%	-$37.5M-1070.0%	-$3.2M+43.0%	-$5.6M+33.6%	-$8.5M+44.2%	-$15.2M+66.2%	-$44.9M+71.6%	-$157.8M-492.2%	-$26.7M+35.9%	-$41.6M+0.7%	-$41.9M+14.5%	-$49.0M+9.6%	-$54.2M
Financing Cash Flow	-$53.3M	-$44.9M+56.4%	-$103.1M-131.3%	-$44.6M-205.4%	$42.3M+274.0%	-$24.3M+3.5%	-$25.2M-2.5%	-$24.6M+75.2%	-$99.2M-17814.1%	$560K+102.6%	-$21.9M+70.2%	-$73.6M+60.6%	-$186.8M-5648.8%	$3.4M-72.5%	$12.3M+140.4%	$5.1M
Dividends Paid	N/A	$0-100.0%	$75.0M	$0	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Share Buybacks	$14.1M	$9.3M	$0	$0-100.0%	$20.8M-14.0%	$24.2M-3.2%	$25.0M-5.9%	$26.6M-73.4%	$100.0M	$0-100.0%	$24.2M-68.0%	$75.8M-60.2%	$190.2M+1802.0%	$10.0M	N/A	N/A

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Operating Cash Flow	$37.0M+86.6%	$19.8M-62.0%	$52.2M+8.0%	$48.4M-18.3%	$59.2M+90.4%	$31.1M-14.5%	$36.3M+67.3%	$21.7M
Investing Cash Flow	-$13.2M-135.0%	-$5.6M+43.5%	-$10.0M-112.8%	$77.6M+223.4%	-$62.9M-167.9%	-$23.5M+67.4%	-$72.0M-146.8%	$153.7M
Financing Cash Flow	-$2.4M+85.9%	-$16.9M-507.2%	-$2.8M+91.1%	-$31.2M-1376.7%	$2.4M+118.2%	-$13.4M-220.3%	$11.1M+113.1%	-$85.3M
Dividends Paid	N/A	N/A	$0	N/A	N/A	N/A	$0	N/A
Share Buybacks	-$1K-100.0%	$14.1M	$0	$0-100.0%	$8.7M+1282.4%	$626K	$0	$0

Not reported in any period shown, so not listed: Capital Expenditures, Free Cash Flow.

INVX Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

INVX quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Gross Margin	31.0%-4.2pp	35.2%0.0pp	35.2%+20.6pp	14.6%+10.5pp	4.1%-22.0pp	26.1%-2.8pp	28.9%+5.2pp	23.7%-3.8pp	27.5%-11.6pp	39.0%-6.6pp	45.6%+0.8pp	44.8%+3.8pp	41.1%+2.7pp	38.4%-1.5pp	39.8%
Operating Margin	13.6%+6.1pp	7.4%-10.1pp	17.5%-3.5pp	21.0%+59.8pp	-38.9%-21.5pp	-17.4%-18.1pp	0.7%+32.6pp	-31.9%-16.7pp	-15.2%-36.1pp	20.9%-8.5pp	29.5%-0.5pp	29.9%+4.3pp	25.6%+3.6pp	22.1%+0.5pp	21.6%
Net Margin	8.5%-12.7pp	21.2%+7.9pp	13.3%-4.2pp	17.5%+57.3pp	-39.9%-31.4pp	-8.4%-8.8pp	0.4%+25.3pp	-24.9%-2.8pp	-22.1%-39.4pp	17.3%-5.4pp	22.7%+0.3pp	22.4%+2.9pp	19.5%+3.2pp	16.3%+0.4pp	15.8%
Return on Equity	7.9%-6.8pp	14.6%-7.8pp	22.5%-2.7pp	25.2%+96.4pp	-71.2%-68.2pp	-2.9%-3.1pp	0.2%+8.9pp	-8.7%-1.0pp	-7.8%-14.6pp	6.9%-7.6pp	14.5%-2.3pp	16.8%+3.1pp	13.7%+2.5pp	11.2%+0.9pp	10.3%
Return on Assets	6.6%-5.2pp	11.7%-3.8pp	15.6%+9.0pp	6.5%+19.2pp	-12.7%-10.1pp	-2.7%-2.8pp	0.1%+8.2pp	-8.0%-0.8pp	-7.2%-13.6pp	6.4%-7.1pp	13.4%-1.0pp	14.4%+2.2pp	12.2%+2.6pp	9.5%+0.8pp	8.8%
Current Ratio	4.91+1.0x	3.94+0.3x	3.67-4.9x	8.57+0.6x	7.95-2.1x	10.09+1.0x	9.08-1.4x	10.46+0.4x	10.09-0.3x	10.41-0.7x	11.15+5.5x	5.67-1.6x	7.23+1.3x	5.96+0.7x	5.29
Debt-to-Equity	0.020.0x	0.03-0.1x	0.12-2.7x	2.86-1.7x	4.59+4.5x	0.110.0x	0.110.0x	0.090.0x	0.080.0x	0.080.0x	0.08-0.1x	0.160.0x	0.120.0x	0.15+0.2x	0.00
FCF Margin	N/A	N/A	7.8%+14.6pp	-6.8%-15.6pp	8.8%+17.9pp	-9.0%-9.8pp	0.8%-2.7pp	3.5%-14.2pp	17.6%-23.3pp	41.0%+21.7pp	19.3%+7.8pp	11.5%-2.2pp	13.7%+21.8pp	-8.0%-15.6pp	7.6%

Metric	Q2'26	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24
Gross Margin	34.2%-1.2pp	35.4%+6.4pp	28.9%-2.7pp	31.6%-0.3pp	32.0%+0.2pp	31.8%-8.6pp	40.4%+5.7pp	34.7%
Operating Margin	13.8%+22.9pp	-9.1%-18.6pp	9.4%-16.5pp	25.9%+15.8pp	10.1%+1.0pp	9.1%-0.6pp	9.7%+18.4pp	-8.7%
Net Margin	10.2%+17.2pp	-7.0%-12.1pp	5.1%-11.2pp	16.4%+9.5pp	6.8%+0.7pp	6.1%-5.3pp	11.4%-43.0pp	54.4%
Return on Equity	2.4%+4.0pp	-1.6%-2.9pp	1.3%-2.5pp	3.8%+2.2pp	1.5%0.0pp	1.5%-1.8pp	3.3%-5.8pp	9.1%
Return on Assets	1.9%+3.2pp	-1.3%-2.4pp	1.1%-2.0pp	3.1%+1.9pp	1.3%0.0pp	1.2%-1.4pp	2.6%-4.6pp	7.3%
Current Ratio	5.01-0.1x	5.10+0.2x	4.91+0.1x	4.78+0.2x	4.60+0.3x	4.34+0.4x	3.94+0.1x	3.87
Debt-to-Equity	0.020.0x	0.020.0x	0.020.0x	0.020.0x	0.030.0x	0.020.0x	0.030.0x	0.01

Not reported in any period shown, so not listed: FCF Margin.

Similar Companies

Enerflex EFXT

$2.5B

Bristow Group Inc VTOL

$1.4B

Select Water Solutions WTTR

$2.5B

National Energy Services Reuni NESR

$3.5B

Mrc Global Inc MRC

$1.2B

Where Innovex International Inc Ranks

Frequently Asked Questions

What is Innovex International Inc's annual revenue?

Innovex International Inc (INVX) reported $978.3M in total revenue for fiscal year 2025. This represents a 48.0% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Innovex International Inc's revenue growing?

Innovex International Inc (INVX) revenue grew by 48.0% year-over-year, from $660.8M to $978.3M in fiscal year 2025.

Is Innovex International Inc profitable?

Yes, Innovex International Inc (INVX) reported a net income of $83.3M in fiscal year 2025, with a net profit margin of 8.5%.

What is Innovex International Inc's EBITDA?

Innovex International Inc (INVX) had EBITDA of $193.4M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

How much debt does Innovex International Inc have?

As of fiscal year 2025, Innovex International Inc (INVX) had $203.4M in cash and equivalents against $18.9M in long-term debt.

What is Innovex International Inc's gross margin?

Innovex International Inc (INVX) had a gross margin of 31.0% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Innovex International Inc's operating margin?

Innovex International Inc (INVX) had an operating margin of 13.6% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Innovex International Inc's net profit margin?

Innovex International Inc (INVX) had a net profit margin of 8.5% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Innovex International Inc's return on equity (ROE)?

Innovex International Inc (INVX) has a return on equity of 7.9% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Innovex International Inc's operating cash flow?

Innovex International Inc (INVX) generated $190.9M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

What are Innovex International Inc's total assets?

Innovex International Inc (INVX) had $1.3B in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Innovex International Inc spend on research and development?

Innovex International Inc (INVX) invested $6.7M in research and development during fiscal year 2025.

Does Innovex International Inc buy back shares?

Yes, Innovex International Inc (INVX) spent $9.3M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

How many shares does Innovex International Inc have outstanding?

Innovex International Inc (INVX) had 69M shares outstanding as of fiscal year 2025.

What is Innovex International Inc's current ratio?

Innovex International Inc (INVX) had a current ratio of 4.91 as of fiscal year 2025, which is generally considered healthy.

What is Innovex International Inc's debt-to-equity ratio?

Innovex International Inc (INVX) had a debt-to-equity ratio of 0.02 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Innovex International Inc's return on assets (ROA)?

Innovex International Inc (INVX) had a return on assets of 6.6% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Innovex International Inc's Altman Z-Score?

Innovex International Inc (INVX) has an Altman Z-Score of 7.98, placing it in the Safe Zone (low bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Innovex International Inc's Piotroski F-Score?

Innovex International Inc (INVX) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Innovex International Inc's earnings high quality?

Innovex International Inc (INVX) has an earnings quality ratio of 2.29x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Innovex International Inc cover its interest payments?

Innovex International Inc (INVX) has an interest coverage ratio of 51.37x, meaning it can comfortably cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Innovex International Inc?

Innovex International Inc (INVX) scores 73 out of 100 on our Financial Health Score, indicating strong standing within its energy companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.